Shunichiro Matsumoto
Director/Board Member at Mitobridge, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Luke Evnin | M | 60 |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | - |
| Drew Pardoll | M | - |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | 10 years |
| Hiroshi Yamamoto | M | - |
Ono Venture Investment, Inc.
 Ono Venture Investment, Inc. Investment ManagersFinance Ono Venture Investment Inc (Ono Venture Investment) is a venture capital arm of Ono Pharmaceutical Co Ltd. founded in 2020. The firm is headquartered in San Francisco, California. | 4 years |
| Kunihiko Ito | M | - |
Ono Pharma USA, Inc.
 Ono Pharma USA, Inc. Internet Software/ServicesTechnology Services Part of Ono Pharmaceutical Co., Ltd., Ono Pharma USA, Inc. operates as a pharmaceutical platform. The company is based in Cambridge, MA. The company was founded in 1998. The CEO is Kunihiko Ito. | - |
| Kiyoaki Idemitsu | M | 60 | 3 years | |
| Tadayoshi Hirata | M | - |
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California.
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | 11 years |
| Shontelle Dodson | M | 53 |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | 12 years |
| David Barrett | M | - |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | 2 years |
| Mark Reisenauer | M | 58 |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | 13 years |
| Nahrin Marino | F | - |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | 14 years |
| Eileen McCullough | F | - |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | - |
| Tomotaka Okino | M | - |
Ono Venture Investment, Inc.
Ono Venture Investment, Inc. Investment ManagersFinance Ono Venture Investment Inc (Ono Venture Investment) is a venture capital arm of Ono Pharmaceutical Co Ltd. founded in 2020. The firm is headquartered in San Francisco, California. | 4 years |
| Richard H. Aldrich | M | 69 |
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | - |
| Ansbert Gadicke | M | 66 |
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | - |
| Arnold Lewis Oronsky | M | 83 |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | - |
| Toshihiro Kameda | M | 56 |
University of Tsukuba
| 27 years |
| Mark Wanda | M | - |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | 11 years |
| Roderick Christmon | M | - |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | 16 years |
| Ana Carrizosa Anderson | M | - |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | - |
| Charles G. Drake | M | 83 |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | - |
| Dario Vignali | M | - |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | - |
| Jedd D. Wolchok | M | - |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | - |
| Lisa Paborsky | M | - |
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | - |
| David N. Cordo | M | - |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | - |
| Yukio Sugiura | M | 82 |
Kyoto University
| 36 years |
| Viviane Yargeau | M | - |
McGill University
| 20 years |
| Toichi Takino | M | 55 |
Ono Pharma USA, Inc.
Ono Pharma USA, Inc. Internet Software/ServicesTechnology Services Part of Ono Pharmaceutical Co., Ltd., Ono Pharma USA, Inc. operates as a pharmaceutical platform. The company is based in Cambridge, MA. The company was founded in 1998. The CEO is Kunihiko Ito. | - |
| Kazuo Yoshida | M | 76 |
Kyoto University
| 37 years |
| Vijay Kumar Kuchroo | M | 69 |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Isaac Langleben | M | - |
McGill University
| 7 years |
| Mark Monaghan | M | - |
McGill University
| 11 years |
| Koji Hanasaki | M | - |
Kyoto University
| 5 years |
| Mahfuzul Hoque | M | - |
University of Tsukuba
| 4 years |
| Takeshi Ebisu | M | 61 |
Kyoto University
| - |
| Makoto Ohori | M | - |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | 7 years |
| Junaid Subhan | M | - |
McGill University
| 8 years |
| Yoshihiko Hatanaka | M | 67 |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | 3 years |
| Nobuaki Shindoh | M | - |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | 2 years |
| Wei Wang | M | 64 |
Kyoto University
| 4 years |
| Reuben Kobulnik | M | - |
McGill University
| 7 years |
| Omar Zahr | M | - |
McGill University
| 11 years |
| Toshihiko Terao | M | 59 |
Kyoto University
| 6 years |
| Francois Beaudry | M | - |
McGill University
| 4 years |
| Simon Bedard | M | - |
McGill University
| 2 years |
| Gabriella Krista Morgan | F | - |
McGill University
| 4 years |
| Christian Hoffmann | M | - |
McGill University
| 3 years |
| Peter Thibodeau | M | - |
McGill University
| 3 years |
| Antoine Lourtau | M | - |
McGill University
| 5 years |
| Tim Lamont | M | - |
McGill University
| 4 years |
| Jing Li | M | 43 |
McGill University
| 4 years |
| Jason Robertson | - | - |
McGill University
| 4 years |
| Heather E. L. Munroe-Blum | M | 73 |
McGill University
| 10 years |
| Ryosuke Munakata | M | - |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | 2 years |
| Peter Amelunxen | M | - |
McGill University
| 3 years |
| Aaron Vale | M | - |
McGill University
| 4 years |
| Nicolas Kassab | M | - |
McGill University
| 4 years |
| Dan Solomon | M | - |
McGill University
| 4 years |
| Erik Groot | M | - |
McGill University
| 4 years |
| Chris Savile | M | - |
McGill University
| 3 years |
| Peter Wright | M | - |
McGill University
| 3 years |
| Hafeez Shariff | M | - |
McGill University
| 4 years |
| Sarah Berner | F | - |
McGill University
| 4 years |
| Darim Abdullah | M | - |
McGill University
| 4 years |
| Alex Bondar | M | - |
McGill University
| 4 years |
| Rami Hannoush | M | - |
McGill University
| 4 years |
| You Yang Li | M | 48 |
McGill University
| 4 years |
| Krystal Chong | F | - |
McGill University
| 4 years |
| Aaron Lapierre | M | - |
McGill University
| 4 years |
| Nick Perkell | M | - |
McGill University
| 4 years |
| Kenzie Lee Shaw | F | - |
McGill University
| 4 years |
| John Henry Goldsmith | M | - |
McGill University
| 2 years |
| Anupam K. Palit | M | - |
McGill University
| 4 years |
| Stefan Quenneville | M | - |
McGill University
| 2 years |
| Stéphane Lévy | M | - |
McGill University
| 3 years |
| Jan Alan Alfheim | M | - |
McGill University
| 2 years |
| Anastasios Avgeriou | M | - |
McGill University
| 2 years |
| Michael Dunn | M | - |
McGill University
| 2 years |
| Fraser Buchan | M | 40 |
McGill University
| 4 years |
| Lindsay Wortzman | F | - |
McGill University
| 4 years |
| Tong Tong Zhao | F | 57 |
McGill University
| 2 years |
| Josh Goldman | M | 41 |
McGill University
| 3 years |
| Dan Solomon | M | - |
McGill University
| 4 years |
| Francoise Forel | M | - |
McGill University
| 5 years |
| Guillaume Gilliard | M | - |
McGill University
| 4 years |
| Jonathan Hera | M | - |
McGill University
| 2 years |
| Matthew James Ruban | M | - |
McGill University
| 4 years |
| Dan Park | M | - |
McGill University
| 5 years |
| Rahim A. Ladak | M | - |
McGill University
| 3 years |
| Melissa Reiter | F | - |
McGill University
| 3 years |
| Elizabeth Joy Zalman | F | - |
McGill University
| 2 years |
| Yassen Plamenov Bogoev | M | - |
McGill University
| 4 years |
| Salim Ben Mansour | M | - |
McGill University
| 3 years |
| Justin Campeau | M | - |
McGill University
| 4 years |
| Vasilios Tsimiklis | M | - |
McGill University
| 2 years |
| Yan Truong | M | - |
McGill University
| 4 years |
| Aaron Lipton | M | - |
McGill University
| 4 years |
| François Ravenelle | M | - |
McGill University
| 3 years |
| Drew Taylor Callander | M | - |
McGill University
| 4 years |
| Sean Macdonald Driscoll | M | - |
McGill University
| 4 years |
| Karim Tajdin | M | - |
McGill University
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 63 | 63.00% |
| United States | 28 | 28.00% |
| Japan | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shunichiro Matsumoto
- Personal Network
